September 25, 2020
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.
September 21, 2020
One in seven black women with breast cancer had delays in starting treatment according to a study led by UNC Lineberger researchers Melissa Troester, PhD, and Marc Emerson, PhD.
July 23, 2020
CAR-T immunotherapy has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
June 15, 2020
Research led by Stephanie Wheeler, PhD, MPH, and Justin Trogdon, PhD, revealed the largest expected costs for treating metastatic breast cancer were among women age 18-44.
April 21, 2020
Kirsten Nyrop, PhD, Hyman Muss, MD, and colleagues compared how women with breast cancer rated the severity of 17 of their own symptoms with physician ratings of chemotherapy toxicity.
February 13, 2020
Researchers led by Gaorav Gupta, MD, PhD, found that disruption of the Mre11 gene's function plays a key role in the genomic instability of triple negative breast cancer.
February 7, 2020
Researchers led by Yuliya Pylayeva-Gupta, PhD, have identified the culprit that keeps cancer-killing immune cells from reaching pancreatic cancer tumors. Their findings were published in the journal Cancer Immunology Research.
February 4, 2020
An experimental blood test accurately detected HPV-linked head and neck cancer recurrence and confirmed when patients remained cancer-free.
February 3, 2020
Tumors can create a hostile environment for cancer-fighting immune cells. In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a method for engineering immune cells to improve their survival and proliferation, even within a hostile tumor. Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature …
November 5, 2019
A University of North Carolina Lineberger Comprehensive Cancer Center-led research team has used genetic insights about head and neck cancers linked to HPV, or human papillomavirus, to improve laboratory tools for studying the disease. Leveraging their discovery that different subtypes of HPV-linked oropharyngeal squamous cell carcinoma exist based on the expression levels of two different …
